Citation: J. Cilia et al., Clozapine enhances breakpoint in common marmosets responding on a progressive ratio schedule, PSYCHOPHAR, 155(2), 2001, pp. 135-143
Authors:
Duxon, MS
Stretton, J
Starr, K
Jones, DNC
Holland, V
Riley, G
Jerman, J
Brough, S
Smart, D
Johns, A
Chan, W
Porter, RA
Upton, N
Citation: Ms. Duxon et al., Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX1) receptors, with downstream 5-HT2C receptor involvement, PSYCHOPHAR, 153(2), 2001, pp. 203-209
Authors:
Jones, DNC
Gartlon, J
Parker, F
Taylor, SG
Routledge, C
Hemmati, P
Munton, RP
Ashmeade, TE
Hatcher, JP
Johns, A
Porter, RA
Hagan, JJ
Hunter, AJ
Upton, N
Citation: Dnc. Jones et al., Effects of centrally administered orexin-1 and orexinA: a role for orexin-1 receptors in orexin-B-induced hyperactivity, PSYCHOPHAR, 153(2), 2001, pp. 210-218
Authors:
Prosser, HM
Gill, CH
Hirst, WD
Grau, E
Robbins, M
Calver, A
Soffin, EM
Farmer, CE
Lanneau, C
Gray, J
Schenck, E
Warmerdam, BS
Clapham, C
Reavill, C
Rogers, DC
Stean, T
Upton, N
Humphreys, K
Randall, A
Geppert, M
Davies, CH
Pangalos, MN
Citation: Hm. Prosser et al., Epileptogenesis and enhanced prepulse inhibition in GABA(B1)-deficient mice, MOL CELL NE, 17(6), 2001, pp. 1059-1070
Authors:
Rodgers, RJ
Halford, JCG
de Souza, RLN
de Souza, ALC
Piper, DC
Arch, JRS
Upton, N
Porter, RA
Johns, A
Blundell, JE
Citation: Rj. Rodgers et al., SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats, EUR J NEURO, 13(7), 2001, pp. 1444-1452
Authors:
Bingham, S
Davey, PT
Babbs, AJ
Irving, EA
Sammons, MJ
Wyles, M
Jeffrey, P
Cutler, L
Riba, I
Johns, A
Porter, RA
Upton, N
Hunter, AJ
Parsons, AA
Citation: S. Bingham et al., Orexin-A, an hypothalamic peptide with analgesic properties, PAIN, 92(1-2), 2001, pp. 81-90
Authors:
Billinton, A
Baird, VH
Thom, M
Duncan, JS
Upton, N
Bowery, NG
Citation: A. Billinton et al., GABA(B(1)) mRNA expression in hippocampal sclerosis associated with human temporal lobe epilepsy, MOL BRAIN R, 86(1-2), 2001, pp. 84-89
Authors:
Billinton, A
Baird, VH
Thom, M
Duncan, JS
Upton, N
Bowery, NG
Citation: A. Billinton et al., GABA(B) receptor autoradiography in hippocampal sclerosis associated with human temporal lobe epilepsy, BR J PHARM, 132(2), 2001, pp. 475-480
Citation: Sj. Read et al., Cortical spreading depression produces increased cGMP levels in cortex andbrain stem that is inhibited by tonabersat (SB-220453) but not sumatriptan, BRAIN RES, 891(1-2), 2001, pp. 69-77
Authors:
Billinton, A
Stean, TO
Bowery, NG
Upton, N
Citation: A. Billinton et al., GABA(B(1)) splice variant mRNAs are differentially affected by electroshock induced seizure in rats, NEUROREPORT, 11(17), 2000, pp. 3817-3822
Authors:
MaassenVanDenBrink, A
van den Broek, RWM
de Vries, R
Upton, N
Parsons, AA
Saxena, PR
Citation: A. Maassenvandenbrink et al., The potential anti-migraine compound SB-220453 does not contract human isolated blood vessels or myocardium; a comparison with sumatriptan, CEPHALALGIA, 20(6), 2000, pp. 538-545
Authors:
Smith, MI
Read, SJ
Chan, WN
Thompson, M
Hunter, AJ
Upton, N
Parsons, AA
Citation: Mi. Smith et al., Repetitive cortical spreading depression in a gyrencephalic feline brain: inhibition by the novel benzoylamino-benzopyran SB-220453, CEPHALALGIA, 20(6), 2000, pp. 546-553
Authors:
Read, SJ
Smith, MI
Hunter, AJ
Upton, N
Parsons, AA
Citation: Sj. Read et al., SB-220453, a potential novel antimigraine agent, inhibits nitric oxide release following induction of cortical spreading depression in the anaesthetized cat, CEPHALALGIA, 20(2), 2000, pp. 92-99
Authors:
Routledge, C
Bromidge, SM
Moss, SF
Price, GW
Hirst, W
Newman, H
Riley, G
Gager, T
Stean, T
Upton, N
Clarke, SE
Brown, AM
Middlemiss, DN
Citation: C. Routledge et al., Characterization of SB-271046: A potent, selective and orally active 5-HT6receptor antagonist, BR J PHARM, 130(7), 2000, pp. 1606-1612
Citation: Ms. Duxon et al., Latency to paroxetine-induced anxiolysis in the rat is reduced by co-administration of the 5-HT1A receptor antagonist WAY100635, BR J PHARM, 130(7), 2000, pp. 1713-1719
Authors:
Hagan, JJ
Price, GW
Jeffrey, P
Deeks, NJ
Stean, T
Piper, D
Smith, MI
Upton, N
Medhurst, AD
Middlemiss, DN
Riley, GJ
Lovell, PJ
Bromidge, SM
Thomas, DR
Citation: Jj. Hagan et al., Characterization of SB-269970-A, a selective 5-HT7 receptor antagonist, BR J PHARM, 130(3), 2000, pp. 539-548
Authors:
Chan, WN
Evans, JM
Hadley, MS
Herdon, HJ
Jerman, JC
Parsons, AA
Read, SJ
Stean, TO
Thompson, M
Upton, N
Citation: Wn. Chan et al., Identification of (-)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent, BIOORG MED, 9(2), 1999, pp. 285-290
Authors:
Hagan, JJ
Leslie, RA
Patel, S
Evans, ML
Wattam, TA
Holmes, S
Benham, CD
Taylor, SG
Routledge, C
Hemmati, P
Munton, RP
Ashmeade, TE
Shah, AS
Hatcher, JP
Hatcher, PD
Jones, DNC
Smith, MI
Piper, DC
Hunter, AJ
Porter, RA
Upton, N
Citation: Jj. Hagan et al., Orexin A activates locus coeruleus cell firing and increases arousal in the rat, P NAS US, 96(19), 1999, pp. 10911-10916
Citation: A. Billinton et al., GABA(B) receptor isoforms GBR1a and GBR1b, appear to be associated with pre- and post-synaptic elements respectively in rat and human cerebellum, BR J PHARM, 126(6), 1999, pp. 1387-1392
Citation: J. Cilia et al., A comparison of rectal and subcutaneous body temperature measurement in the common marmoset, J PHARM TOX, 40(1), 1998, pp. 21-26